What is the recommended dose of clindamycin (antibiotic) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clindamycin Dosing for Pediatric Patients

For pediatric patients, clindamycin should be dosed at 40 mg/kg/day divided every 6-8 hours for parenteral (IV) administration, or 30-40 mg/kg/day divided into 3-4 doses for oral administration, based on current guidelines from the Pediatric Infectious Diseases Society, Infectious Diseases Society of America, and American Academy of Pediatrics. 1, 2

Parenteral (Intravenous) Dosing

Standard Dosing

  • Administer 40 mg/kg/day divided every 6-8 hours (equivalent to 10-13 mg/kg/dose every 6-8 hours, not to exceed 40 mg/kg/day total) for serious infections including MRSA, MSSA, Group A Streptococcus, and pneumonia 1, 2
  • This dosing applies across most serious bacterial infections requiring IV therapy 2

Pathogen-Specific Considerations

  • For MRSA infections in stable children without ongoing bacteremia: 10-13 mg/kg/dose IV every 6-8 hours 2
  • For Group A Streptococcal infections: 40 mg/kg/day every 6-8 hours 1, 2
  • For Streptococcus pneumoniae infections: 40 mg/kg/day every 6-8 hours 2

Oral Dosing

Standard Dosing

  • For serious infections: 8-16 mg/kg/day divided into 3-4 equal doses 3
  • For more severe infections: 16-20 mg/kg/day divided into 3-4 equal doses 3
  • For MRSA/MSSA infections: 30-40 mg/kg/day divided into 3-4 doses 1, 2

Pathogen-Specific Oral Dosing

  • For Group A Streptococcus infections: 40 mg/kg/day in 3 doses 1, 2
  • For cellulitis secondary to abscess in penicillin-allergic patients: 10-20 mg/kg/day divided into 3 doses 2

Special Population: Neonates and Premature Infants

Newborn infants require significantly reduced dosing due to prolonged elimination half-life (6.3 hours vs. 3 hours in older children) and lower clearance. 4

  • Recommended dose for neonates: 15-20 mg/kg/day given in 4 divided doses 4
  • Maturation of clindamycin clearance reaches 50% of adult values at approximately 44 weeks postmenstrual age 5
  • For infants ≤5 months: Consider 9 mg/kg/dose every 8 hours for IV administration 6
  • For infants >5 months to 6 years: 12 mg/kg/dose every 8 hours 6
  • For children 6-18 years: 10 mg/kg/dose every 8 hours 6

Important Clinical Considerations

Administration Guidelines

  • Clindamycin should be dosed based on total body weight regardless of obesity 3
  • Oral capsules should be taken with a full glass of water to avoid esophageal irritation 3
  • Capsules are not suitable for children unable to swallow them whole; use clindamycin palmitate oral solution instead 3

Duration of Therapy

  • For β-hemolytic streptococcal infections: Continue treatment for at least 10 days 3
  • For pneumonia: 7-21 days depending on extent of infection 2
  • For bacteremia and endocarditis: 2-6 weeks depending on source and presence of endovascular infection 2
  • For osteomyelitis: Minimum 8-week course, though older studies used 50 mg/kg/day IV for 3 weeks followed by 30 mg/kg/day orally for 6 weeks 2, 7

Critical Caveats and Pitfalls

  • Clindamycin should only be used if local MRSA clindamycin resistance rates are <10% 2
  • Do not use if there is concern for infective endocarditis or endovascular source of infection 2
  • Discontinue immediately if significant diarrhea occurs due to risk of Clostridioides difficile-associated diarrhea 3
  • Loose stools occur in approximately 1-7% of patients, with rash developing rarely 8

Transition Strategy

  • For severe infections requiring IV therapy initially, transition to oral therapy after clinical improvement (typically 48-72 hours of being afebrile) 2
  • Total duration of therapy (IV plus oral) should be 7-14 days for most skin and soft tissue infections, with adjustments based on clinical response 2

References

Guideline

Clindamycin Dosing for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Clindamycin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of intravenous clindamycin in newborn infants.

Pediatric pharmacology (New York, N.Y.), 1986

Research

Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases.

American journal of diseases of children (1960), 1977

Research

Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.